Neostigmine Methylsulfate Injection
Product Images NDC 65145-112

7 FDA label images from Caplin Steriles Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Neostigmine Methylsulfate (NDC 65145-112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Caplin Steriles Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Neostigmine1 (Neostigmine1)

Neostigmine1 (Neostigmine1)
Chemical structure of Neostigmine Methylsulfate depicting its molecular arrangement including functional groups and sulfate ion.*
FDA Label Image

Image2 (Neostigmine2)

Image2 (Neostigmine2)
Label for Neostigmine Methylsulfate Injection, USP 0.5 mg/mL (5 mg/10 mL) in a 10 mL multiple dose vial. The label states it is for intravenous use only and Rx only. Manufacturer is Caplin Steriles Limited, India. Includes storage instructions, ingredient details, barcode, and lot/expiration fields.*
FDA Label Image

Image3 (Neostigmine3)

Image3 (Neostigmine3)
Neostigmine Methylsulfate Injection, USP 0.5 mg/mL (5 mg/10 mL) for intravenous use in 10 multiple dose vials, package label. Manufactured by Caplin Steriles Limited, India, the label includes NDC 65145-111-10 and barcode.*
FDA Label Image

Image4 (Neostigmine4)

Image4 (Neostigmine4)
Neostigmine Methylsulfate Injection, USP 5 mg/10 mL (0.5 mg/mL) label for intravenous use. The carton is for 10 multiple dose vials of 10 mL each. The label includes the NDC 65145-111-10 and states Rx Only. It provides storage instructions, ingredients per mL, and directs users to the package insert for directions.*
FDA Label Image

Image5 (Neostigmine5)

Image5 (Neostigmine5)
Label for Neostigmine Methylsulfate Injection USP, 1 mg/mL strength, provided in a 10 mL multiple dose vial. The label shows it is for intravenous use, manufactured by Caplin Steriles Limited, India. Directions include storage at 20° to 25°C and protection from light.*
FDA Label Image

Image6 (Neostigmine6)

Image6 (Neostigmine6)
Packaging label for Neostigmine Methylsulfate Injection, USP, 1 mg/mL (10 mg/10 mL) multiple dose vials. The label shows the product name, concentration, route of administration (intravenous use), quantity (10×10 mL vials), and manufacturer Caplin Steriles Limited, India, with a barcode and NDC 65145-112-10.*
FDA Label Image

Image7 (Neostigmine7)

Image7 (Neostigmine7)
Neostigmine Methylsulfate Injection, USP 10 mg/10 mL (1 mg/mL) intravenous injection label for multiple dose vials. The label shows storage instructions, includes the NDC 65145-112-10, and is produced by Caplin Steriles Limited. It specifies protection from light and storage at controlled room temperature.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.